Tumor marker assessment points to ponder

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)284-286
Number of pages3
JournalCancer Biology and Therapy
Volume11
Issue number2
DOIs
StatePublished - Jan 15 2011

Fingerprint

Cathepsin D
Plasminogen Activator Inhibitor 1
Urokinase-Type Plasminogen Activator
Tumor Biomarkers
Estrogen Receptors
Peptide Hydrolases
Breast Neoplasms

Keywords

  • Breast cancer
  • Cathepsin D (cath-D)
  • Estrogen receptor (ER)
  • Plasminogen activator inhibitor type-1 (PAI-1)
  • Prognosis
  • Tumor marker
  • Urokinase-type plasminogen activator (uPA)

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Tumor marker assessment points to ponder. / Polar, Yesim; Badve, Sunil.

In: Cancer Biology and Therapy, Vol. 11, No. 2, 15.01.2011, p. 284-286.

Research output: Contribution to journalArticle

@article{89dca72320c8441ca62256a3b9d2778f,
title = "Tumor marker assessment points to ponder",
keywords = "Breast cancer, Cathepsin D (cath-D), Estrogen receptor (ER), Plasminogen activator inhibitor type-1 (PAI-1), Prognosis, Tumor marker, Urokinase-type plasminogen activator (uPA)",
author = "Yesim Polar and Sunil Badve",
year = "2011",
month = "1",
day = "15",
doi = "10.4161/cbt.11.2.14370",
language = "English",
volume = "11",
pages = "284--286",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Tumor marker assessment points to ponder

AU - Polar, Yesim

AU - Badve, Sunil

PY - 2011/1/15

Y1 - 2011/1/15

KW - Breast cancer

KW - Cathepsin D (cath-D)

KW - Estrogen receptor (ER)

KW - Plasminogen activator inhibitor type-1 (PAI-1)

KW - Prognosis

KW - Tumor marker

KW - Urokinase-type plasminogen activator (uPA)

UR - http://www.scopus.com/inward/record.url?scp=78751564528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751564528&partnerID=8YFLogxK

U2 - 10.4161/cbt.11.2.14370

DO - 10.4161/cbt.11.2.14370

M3 - Article

VL - 11

SP - 284

EP - 286

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 2

ER -